Effectiveness of IV cyclophosphamide and mycophenolate mofetil in the treatment of childhood-onset lupus nephritis in a resource-limited setting
Lupus nephritis (LN) is a major cause of morbidity in childhood-onset systemic lupus erythematosus (cSLE). Cyclophosphamide (CYC) and mycophenolate mofetil (MMF) are recommended first-line induction therapies, yet comparative pediatric real-world data, particularly from Asian po…